SCHEMBL27357166

SCHEMBL27357166

Cc1c(NC(=O)c2ccco2)ccc2c1COC(NCCc1ccccc1)=N2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
RAB9A P51151 4/20 0.44
NPC1 O15118 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GAA P10253 2/20 0.41
ALDH1A1 P00352 5/20 0.41
LMNA P02545 3/20 0.41
KMT2A Q03164 5/20 0.41
MEN1 O00255 3/20 0.40
PKM P14618 2/20 0.40
ALOX12 P18054 1/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.39
TSHR P16473 2/20 0.39
TP53 P04637 1/20 0.39
HTT P42858 2/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27363422 0.85 KMT2A (0.44) SMN1; SMN2RAB9ANPC1KMT2AMEN1
SCHEMBL27355463 0.83 CTRB1 (0.38) NPC1ALDH1A1KMT2AMEN1KDM4E
SCHEMBL27383640 0.81 ALDH1A1 (0.41) SMN1; SMN2RAB9ANPC1GAAALDH1A1
SCHEMBL27381422 0.80 LTA4H (0.39) SMN1; SMN2RAB9ANPC1ALDH1A1KMT2A
SCHEMBL27362428 0.76 PKM (0.35) SMN1; SMN2RAB9ANPC1L3MBTL1GAA
SCHEMBL27364669 0.74 NPC1 (0.34) ATMSMN1; SMN2RAB9ANPC1L3MBTL1
SCHEMBL27355461 0.74 F2 (0.38) SMN1; SMN2RAB9ANPC1ALDH1A1KMT2A
SCHEMBL27362385 0.73 TAAR1 (0.37) ATMSMN1; SMN2RAB9ANPC1L3MBTL1
SCHEMBL6496069 0.70 ELANE (0.50) ATMSMN1; SMN2RAB9ANPC1L3MBTL1
SCHEMBL27357170 0.67 HDAC6 (0.38) ATMRAB9ANPC1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1070480-C 2-amino-benzoxanones for the treatment of viral infections SEARLE & CO (US) 2001-09-05 CN disclosed